Latest Breaking News On - Hanmi pharmaceutical inc - Page 1 : vimarsana.com

Aptose Reports Results For The First Quarter 2024

Aptose Reports Results For The First Quarter 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesAptose biosciencesSusan pietropaoloDrug administrationExchange commissionNasdaq stock marketEuropean hematology associationAptose biosciences incListings qualifications departmentCorporate communications investor relationsLifesci advisorsHanmi pharmaceutical incNewly diagnosedNow being activatedClinical sitesCompleted trials

Aptose Biosciences (APTO) Prices $8 4M Offering

Aptose Biosciences (APTO) Prices $8 4M Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaBoca ratonAptose biosciences incEquity syndicate departmentHanmi pharmaceutical incToronto stock exchangeNewbridge securities corporationCommon shares of the companyCompany manualCompany the commonExchange commissionAptose biosciencesCommon sharePublic offeringCommon shares

Aptose Announces Pricing of $8 4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

Aptose Announces Pricing of $8 4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaUnited statesAptose biosciencesBoca ratonSusan pietropaoloToronto stock exchangeCompany nasdaqCompany manualCommon shares of the companyCorporate communications investor relationsCompany the commonHanmi pharmaceutical incNewbridge securities corporationExchange comissionExchange commission

Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical

Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaSoult ukpyolsiAptose biosciencesSusan pietropaoloToronto stock exchangeCompany manualExchange commissionHanmi pharmaceutical incAptose biosciences incHanmi pharmaceutical co ltdLifesci advisorsCompany theHanmi pharmaceuticalChief executiveJuhyun lim

Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical - Aptose Biosciences (NASDAQ:APTO)

SAN DIEGO and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO, TSX:APS), a clinical-stage precision oncology company developing highly differentiated oral

South koreaSoult ukpyolsiAptose biosciencesAptose biosciences incCompany theHanmi pharmaceutical co ltdToronto stock exchangeCompany manualHanmi pharmaceutical incHanmi pharmaceuticalChief executiveJuhyun limOrphan drug designationPharmacist lim sung ki